CAMBRIDGE, England, Sept. 5, 2023 /PRNewswire/ — Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that Young Kwon, PhD, Chief Executive Officer, will participate in a fireside chat at…